Literature DB >> 35639270

Molecular details of aluminium-amyloid β peptide interaction by nuclear magnetic resonance.

Gayani Petersingham1, Mohammad S Zaman1, Adam J Johnson1, Narsimha Reddy1, Allan M Torres1,2, Ming J Wu3.   

Abstract

Alzheimer's disease (AD) is a devastating neurodegenerative condition that poses major challenges to human health. Both amyloid β (Aβ) and metal ions such as aluminium are implicated in the development of AD. By the means of NMR, the interactions of Al3+ with Aβ1-28 peptide as well as the Aβ1-28 analogues were studied, and the key binding sites of Al3+ in Aβ determined. NMR data showed Al3+ interacts with Aβ1-28 at the NH and αH of numerous residues by exhibiting upfield shifts. Using Aβ analogues where His6, His13 and His14 were individually replaced by alanine residue(s), including Aβ H6A, Aβ H13A, Aβ H14A, and Aβ H6,13,14A, the results demonstrated that the histidine residues (His6, His13 and His14) and N-terminal Asp1 were involved in the Al3+ coordination. These findings provide, for the first time, the details of the molecular interaction between Al3+ and Aβ, which points to the potential role of Al3+ in Aβ aggregation, hence in AD development.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Aluminium; Alzheimer’s disease; Amyloid β; NMR

Mesh:

Substances:

Year:  2022        PMID: 35639270     DOI: 10.1007/s10534-022-00399-0

Source DB:  PubMed          Journal:  Biometals        ISSN: 0966-0844            Impact factor:   3.378


  36 in total

1.  Potential pathogenic role of beta-amyloid(1-42)-aluminum complex in Alzheimer's disease.

Authors:  Denise Drago; Mikol Bettella; Silvia Bolognin; Laura Cendron; Janez Scancar; Radmila Milacic; Fernanda Ricchelli; Angela Casini; Luigi Messori; Giuseppe Tognon; Paolo Zatta
Journal:  Int J Biochem Cell Biol       Date:  2007-10-22       Impact factor: 5.085

Review 2.  Neurobiological aspects of Alzheimer's disease.

Authors:  Kanwaljit Chopra; Shubham Misra; Anurag Kuhad
Journal:  Expert Opin Ther Targets       Date:  2011-02-11       Impact factor: 6.902

3.  Aluminum, copper, iron and zinc differentially alter amyloid-Aβ(1-42) aggregation and toxicity.

Authors:  Silvia Bolognin; Luigi Messori; Denise Drago; Chiara Gabbiani; Laura Cendron; Paolo Zatta
Journal:  Int J Biochem Cell Biol       Date:  2011-03-03       Impact factor: 5.085

Review 4.  The role of tau oligomers in the onset of Alzheimer's disease neuropathology.

Authors:  María del Carmen Cárdenas-Aguayo; Laura Gómez-Virgilio; Steven DeRosa; Marco Antonio Meraz-Ríos
Journal:  ACS Chem Neurosci       Date:  2014-10-15       Impact factor: 4.418

Review 5.  Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer's disease.

Authors:  Sagar H Barage; Kailas D Sonawane
Journal:  Neuropeptides       Date:  2015-07-02       Impact factor: 3.286

Review 6.  Therapeutics for Alzheimer's disease based on the metal hypothesis.

Authors:  Ashley I Bush; Rudolph E Tanzi
Journal:  Neurotherapeutics       Date:  2008-07       Impact factor: 7.620

7.  Circulating Glutamine and Alzheimer's Disease: A Mendelian Randomization Study.

Authors:  Charleen D Adams
Journal:  Clin Interv Aging       Date:  2020-02-10       Impact factor: 4.458

8.  Computational predictions of volatile anesthetic interactions with the microtubule cytoskeleton: implications for side effects of general anesthesia.

Authors:  Travis J A Craddock; Marc St George; Holly Freedman; Khaled H Barakat; Sambasivarao Damaraju; Stuart Hameroff; Jack A Tuszynski
Journal:  PLoS One       Date:  2012-06-25       Impact factor: 3.240

9.  Elevated brain aluminium and early onset Alzheimer's disease in an individual occupationally exposed to aluminium: a case report.

Authors:  Christopher Exley; Thomas Vickers
Journal:  J Med Case Rep       Date:  2014-02-10

10.  Modulation of amyloid-β aggregation by metal complexes with a dual binding mode and their delivery across the blood-brain barrier using focused ultrasound.

Authors:  Tiffany G Chan; Carmen L Ruehl; Sophie V Morse; Michelle Simon; Viktoria Rakers; Helena Watts; Francesco A Aprile; James J Choi; Ramon Vilar
Journal:  Chem Sci       Date:  2021-06-15       Impact factor: 9.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.